Figure 1From: Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy Study population of Pneumocystis jirovecii pneumonia after discontinuation of primary or secondary prophylaxis between April 1997 and December 2007.Back to article page